Mcgill University Health Centre/research Institute Of The Mcgill University Health Centre
Clinical trials sponsored by Mcgill University Health Centre/research Institute Of The Mcgill University Health Centre, explained in plain language.
-
Stem cell shot for COVID lung failure shows early promise
Disease control TerminatedThis study tested whether a single infusion of stem cells from donated umbilical cord tissue could help hospitalized adults with severe COVID-19 avoid breathing machines or death. Nineteen participants received either the stem cells or a placebo, plus standard care. The trial was…
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Early lung cancer drug combo trial halted after just 6 patients
Disease control TerminatedThis study aimed to see if giving the immunotherapy drug pembrolizumab, alone or with chemotherapy, before surgery could help people with early-stage non-small cell lung cancer. Only 6 participants were enrolled before the trial was stopped early. The main goal was to measure cha…
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Lung scarring drug studied in rare muscle disease patients
Disease control TerminatedThis study looked at whether the drug nintedanib is safe and tolerable for people with myositis (a muscle disease) that also causes lung scarring. It included 11 adults who were already on immune-suppressing medications. The goal was to see if adding nintedanib could help slow lu…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
COPD breathlessness study halted: did fentanyl offer relief?
Symptom relief TerminatedThis study looked at whether a fentanyl tablet placed under the tongue could reduce shortness of breath and improve exercise ability in people with severe COPD. The trial included 40 adults aged 40 and older with advanced COPD who still felt breathless despite standard treatments…
Phase: PHASE2, PHASE3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Symptom relief
Last updated May 16, 2026 23:57 UTC